Search hospitals > Missouri > Saint Louis
Washington University School Of Medicine
Claim this profileSaint Louis, Missouri 63110
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Solid Tumors
3130 reported clinical trials
429 medical researchers
Summary
Washington University School Of Medicine is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer, Solid Tumors and other specialties. Washington University School Of Medicine is involved with conducting 3,130 clinical trials across 2,253 conditions. There are 429 research doctors associated with this hospital, such as Robert J. Hayashi, Brian A Van Tine, M.D., Ph.D., Timothy R Smith, and Douglas R. Adkins.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
BRAF positive
2Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
Robert J. HayashiWashington University School of Medicine8 years of reported clinical research
Expert in Cancer
Expert in Solid Tumors
58 reported clinical trials
110 drugs studied
Brian A Van Tine, M.D., Ph.D.Washington University School of Medicine3 years of reported clinical research
Expert in Soft Tissue Sarcoma
Expert in Cancer
49 reported clinical trials
67 drugs studied
Timothy R SmithStudyMetrix Research5 years of reported clinical research
Expert in Obesity
Expert in Childhood Obesity
43 reported clinical trials
39 drugs studied
Douglas R. AdkinsWashington University School of Medicine6 years of reported clinical research
Expert in Squamous Cell Carcinoma
Expert in Head and Neck Squamous Cell Carcinoma
38 reported clinical trials
64 drugs studied
Clinical Trials running at Washington University School Of Medicine
Lung Cancer
Ovarian Cancer
Breast Cancer
Colorectal Cancer
Cancer
Prostate Cancer
Brain Tumor
Neuroblastoma
Esophageal cancer
Breast cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Washington University School Of Medicine?
Washington University School Of Medicine is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer, Solid Tumors and other specialties. Washington University School Of Medicine is involved with conducting 3,130 clinical trials across 2,253 conditions. There are 429 research doctors associated with this hospital, such as Robert J. Hayashi, Brian A Van Tine, M.D., Ph.D., Timothy R Smith, and Douglas R. Adkins.
Where is Washington University School Of Medicine located?
**Washington University School of Medicine Hospital**
- **Location:** Situated in St. Louis, Missouri, on the Washington University Medical Campus, adjacent to Forest Park and the Central West End and Grove neighborhoods. The main entrance is located at 216 S. Kingshighway Blvd, St. Louis, MO, US.
- **Contact Information:** For assistance, please call 314.362.5194 or toll-free at 800.451.4892. Our staff is available to meet you at the door, guide you to your appointment, and assist with any other guest services required.
Who should I call to ask about financial aid or insurance network?
**Washington University School of Medicine Financial Assistance and Insurance Inquiries:**
- Contact the Office of Student Financial Planning for financial assistance and insurance-related inquiries at 314-362-6845 or toll-free at 888-840-3239. Email: MedFinancialAid@wustl.edu. Address: Campus Box 8059, 660 S. Euclid Ave., St. Louis, MO 63110-1093.
**Washington University Physicians Patient Billing and Insurance Issues:**
- For patient billing and insurance-related issues, contact the Patient Services line at 314-273-0500 (option 4) or toll-free at 800-862-9980. Assistance is available 24/7 for automated inquiries and during business hours for live support.
**UW Medicine Financial Assistance for Patients:**
- Patients in need of financial assistance for medically necessary care can access the Financial Assistance Application Form.
What insurance does Washington University School Of Medicine accept?
The Washington University School of Medicine accepts a wide range of insurance plans, including Medicare, commercial health insurance plans, Health Exchange Market plans, and Medicaid Government and Private Providers. They are part of Medicare Government and Private Providers, offering Traditional Medicare Part B and various private Medicare Advantage plans such as Anthem BCBS MediBlue Plus HMO, Cigna Preferred Medicare HMO, and more. For commercial health insurance, they accept plans from providers like Aetna, Anthem BCBS, Cigna, and United HealthCare. It's advised for patients to verify their current coverage with their plan administrator due to possible changes.
What awards or recognition has Washington University School Of Medicine received?
Washington University School of Medicine in St. Louis is renowned for its research excellence, securing over $824.6 million in grants and contracts in the 2023 fiscal year. It boasts 16 fellows of the National Academy of Sciences and 28 members of the National Academy of Medicine. The school is also committed to diversity, equity, and inclusion, with various initiatives to enhance representation in medical research and healthcare professions.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.